106 related articles for article (PubMed ID: 17669237)
1. [Screening low molecular weight protein biomarkers relevant to portal vein tumor thrombi in serum of patients with hepatocellular carcinoma].
Qiu JG; Fan J; Liu YK; Zhou J; Qiu SJ; Dai Z; Kang XN; Huang C; Yang PY; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):498-502. PubMed ID: 17669237
[TBL] [Abstract][Full Text] [Related]
2. Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma.
Qiu JG; Fan J; Liu YK; Zhou J; Dai Z; Huang C; Tang ZY
J Cancer Res Clin Oncol; 2008 Mar; 134(3):299-305. PubMed ID: 17828420
[TBL] [Abstract][Full Text] [Related]
3. [Study of serum proteome biomarkers with relation to the formation of portal vein tumor thrombi in hepatocellular carcinoma patients].
Huang C; Fan J; Zhou J; Liu YK; Cui JF; Kang XN; Yang PY; Tang ZY
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):781-5. PubMed ID: 15949388
[TBL] [Abstract][Full Text] [Related]
4. [The effects of different clinicopathologic variables on serum protein fingerprint in hepatocellular carcinoma patients].
Huang C; Fan J; Zhou J; Liu YK; Cui JF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):445-9. PubMed ID: 16772076
[TBL] [Abstract][Full Text] [Related]
5. Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.
Xu X; Wei X; Ling Q; Cheng J; Zhou B; Xie H; Zhou L; Zheng S
J Gastroenterol Hepatol; 2011 Dec; 26(12):1787-94. PubMed ID: 21649721
[TBL] [Abstract][Full Text] [Related]
6. [Hepatic resection with removal of tumor thrombi for hepatocellular carcinoma with tumor thrombi in portal vein and curative analysis].
Fan J; Wu Z; Tang Z; Yu Y; Zhou J; Qiu S; Zhang B
Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):8-11. PubMed ID: 11829766
[TBL] [Abstract][Full Text] [Related]
7. [The effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma].
Fan J; Tang ZY; Wu ZQ; Zhou J; Zhou XD; Ma ZC; Qin LX; Qiu SJ; Yu Y; Huang C
Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):433-5. PubMed ID: 15854367
[TBL] [Abstract][Full Text] [Related]
8. Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.
Chen XP; Qiu FZ; Wu ZD; Zhang ZW; Huang ZY; Chen YF; Zhang BX; He SQ; Zhang WG
Ann Surg Oncol; 2006 Jul; 13(7):940-6. PubMed ID: 16788755
[TBL] [Abstract][Full Text] [Related]
9. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
10. [Percutaneous laser ablation in the treatment of portal vein tumor thrombus in 93 hepatocellular carcinoma patients].
Lu ZH; Shen F; Yuan GX; Shi LH; Zong M; Yang JH; Guo J; Wu MC
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):449-52. PubMed ID: 17974281
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the serum proteomes of pathological stages during hepatocarcinogenesis].
Shu H; Kang XN; Li M; Guo K; Sun L; Li S; Xie L; Deng JH; Qin X; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):520-5. PubMed ID: 19912687
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation].
Lu ZH; Shen F; Yuan GX; Shi LH; Zhong M; Yang JH; Guo J; Wu MC
Zhonghua Wai Ke Za Zhi; 2004 May; 42(9):566-9. PubMed ID: 15196374
[TBL] [Abstract][Full Text] [Related]
13. [Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma].
Hou YK; Wang Y; Cong WM; Wu MC
Ai Zheng; 2007 Jun; 26(6):591-5. PubMed ID: 17562263
[TBL] [Abstract][Full Text] [Related]
14. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis.
Feng JT; Liu YK; Song HY; Dai Z; Qin LX; Almofti MR; Fang CY; Lu HJ; Yang PY; Tang ZY
Proteomics; 2005 Nov; 5(17):4581-8. PubMed ID: 16240287
[TBL] [Abstract][Full Text] [Related]
15. [Proteomic analysis on portal vein tumor thrombus-associated proteins for hepatocellular carcinoma].
Guo WX; Man XB; Yuan HX; Shi J; Xue J; Wu MC; Cheng SQ
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2094-7. PubMed ID: 17988525
[TBL] [Abstract][Full Text] [Related]
16. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy.
Lin CS; Jen YM; Chiu SY; Hwang JM; Chao HL; Lin HY; Shum WY
Jpn J Clin Oncol; 2006 Apr; 36(4):212-7. PubMed ID: 16613896
[TBL] [Abstract][Full Text] [Related]
17. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors of hepatocellular carcinoma after liver transplantation].
Zhou LX; Yan LN
Ai Zheng; 2006 Jun; 25(6):736-9. PubMed ID: 16764771
[TBL] [Abstract][Full Text] [Related]
19. [Multidisciplinary treatment for advanced hepatocellular carcinoma with portal vein tumor thrombosis and adrenal/lung metastases].
Mizumoto T; Beppu T; Okabe K; Sugiyama S; Nakagawa M; Okabe H; Doi K; Ishiko T; Yamanaka T; Egami H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1921-3. PubMed ID: 15553760
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Wu DH; Chen LH
Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
